Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 90

1.

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.

Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PG.

Clin Infect Dis. 2019 Dec 5. pii: ciz1008. doi: 10.1093/cid/ciz1008. [Epub ahead of print]

PMID:
31802125
2.

Effect of renal clearance and continuous renal replacement therapy on appropriateness of recommended meropenem dosing regimens in critically ill patients with susceptible life-threatening infections.

Burger R, Guidi M, Calpini V, Lamoth F, Decosterd L, Robatel C, Buclin T, Csajka C, Marchetti O.

J Antimicrob Chemother. 2018 Dec 1;73(12):3413-3422. doi: 10.1093/jac/dky370.

PMID:
30304491
3.

Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).

Kritikos A, Neofytos D, Khanna N, Schreiber PW, Boggian K, Bille J, Schrenzel J, Mühlethaler K, Zbinden R, Bruderer T, Goldenberger D, Pfyffer G, Conen A, Van Delden C, Zimmerli S, Sanglard D, Bachmann D, Marchetti O, Lamoth F; Fungal Infection Network of Switzerland (FUNGINOS).

Clin Microbiol Infect. 2018 Nov;24(11):1214.e1-1214.e4. doi: 10.1016/j.cmi.2018.05.012. Epub 2018 Jun 15.

4.

Pentraxin-3 polymorphisms and invasive mold infections in acute leukemia patients receiving intensive chemotherapy.

Brunel AS, Wójtowicz A, Lamoth F, Spertini O, Neofytos D, Calandra T, Marchetti O, Bochud PY.

Haematologica. 2018 Nov;103(11):e527-e530. doi: 10.3324/haematol.2018.195453. Epub 2018 Jun 7. No abstract available.

5.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

6.

Correction to: Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.

Damonti L, Erard V, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Imhof A, Zbinden R, Fehr J, Boggian K, Bruderer T, Flückiger U, Frei R, Orasch C, Conen A, Khanna N, Bregenzer T, Bille J, Lamoth F, Marchetti O, Bochud PY; Fungal Infection Network of Switzerland (FUNGINOS).

Intensive Care Med. 2018 Mar;44(3):405-407. doi: 10.1007/s00134-018-5081-4.

PMID:
29464298
7.

Re: "Comparison of antipseudomonal betalactams for febrile neutropenia empiric therapy: systematic review and network metaanalysis" by Horita et al.

Averbuch D, Orasch C, Mikulska M, Livermore DM, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M, Calandra T, Cordonnier C; ECIL4 antibacterial group, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN.

Clin Microbiol Infect. 2018 Jun;24(6):662-663. doi: 10.1016/j.cmi.2018.01.012. Epub 2018 Feb 2. No abstract available.

8.

Fluconazole non-susceptible breakthrough candidemia after prolonged low-dose prophylaxis: a prospective FUNGINOS study.

Orasch C, Mertz D, Garbino J, van Delden C, Emonet S, Schrenzel J, Zimmerli S, Damonti L, Mühlethaler K, Imhof A, Ruef C, Fehr J, Zbinden R, Boggian K, Bruderer T, Flückiger U, Conen A, Khanna N, Frei R, Bregenzer T, Lamoth F, Erard V, Bochud PY, Calandra T, Bille J, Marchetti O; Fungal Infection Network of Switzerland (FUNGINOS).

J Infect. 2018 May;76(5):489-495. doi: 10.1016/j.jinf.2017.12.018. Epub 2018 Jan 31.

PMID:
29378240
9.

Catheter retention as a consequence rather than a cause of unfavorable outcome in candidemia.

Damonti L, Erard V, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Imhof A, Zbinden R, Fehr J, Boggian K, Bruderer T, Flückiger U, Frei R, Orasch C, Conen A, Khanna N, Bregenzer T, Bille J, Lamoth F, Marchetti O, Bochud PY; Fungal Infection Network of Switzerland (FUNGINOS).

Intensive Care Med. 2017 Jun;43(6):935-939. doi: 10.1007/s00134-017-4737-9. Epub 2017 Mar 7. No abstract available. Erratum in: Intensive Care Med. 2018 Feb 20;:.

PMID:
28271318
10.

Association of lectin pathway proteins with intra-abdominal Candida infection in high-risk surgical intensive-care unit patients. A prospective cohort study within the fungal infection network of Switzerland.

Osthoff M, Wojtowicz A, Tissot F, Jørgensen C, Thiel S, Zimmerli S, Marchetti O, Khanna N, Bochud PY, Trendelenburg M; Fungal Infection Network of Switzerland (FUNGINOS); Fungal Infection Network of Switzerland FUNGINOS.

J Infect. 2016 Mar;72(3):377-85. doi: 10.1016/j.jinf.2015.12.011. Epub 2015 Dec 28.

PMID:
26730718
11.

Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy.

Asner SA, Giulieri S, Diezi M, Marchetti O, Sanglard D.

Antimicrob Agents Chemother. 2015 Dec;59(12):7715-22. doi: 10.1128/AAC.02204-15. Epub 2015 Oct 5.

12.

CSF lactate for accurate diagnosis of community-acquired bacterial meningitis.

Giulieri S, Chapuis-Taillard C, Jaton K, Cometta A, Chuard C, Hugli O, Du Pasquier R, Bille J, Meylan P, Manuel O, Marchetti O.

Eur J Clin Microbiol Infect Dis. 2015 Oct;34(10):2049-55. doi: 10.1007/s10096-015-2450-6. Epub 2015 Aug 19.

PMID:
26282789
13.

Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031).

Cornely OA, Gachot B, Akan H, Bassetti M, Uzun O, Kibbler C, Marchetti O, de Burghgraeve P, Ramadan S, Pylkkanen L, Ameye L, Paesmans M, Donnelly JP; EORTC Infectious Diseases Group.

Clin Infect Dis. 2015 Aug 1;61(3):324-31. doi: 10.1093/cid/civ293. Epub 2015 Apr 13. Erratum in: Clin Infect Dis. 2015 Nov 15;61(10):1635. Donnelly, Peter J [corrected to Donnelly, J Peter].

PMID:
25870323
14.

Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.

Fournier A, Eggimann P, Pagani JL, Revelly JP, Decosterd LA, Marchetti O, Pannatier A, Voirol P, Que YA.

Burns. 2015 Aug;41(5):956-68. doi: 10.1016/j.burns.2015.01.001. Epub 2015 Feb 10.

PMID:
25678084
15.

Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical.

Orasch C, Averbuch D, Mikulska M, Cordonnier C, Livermore DM, Gyssens IC, Klyasova G, Engelhard D, Kern W, Viscoli C, Akova M, Marchetti O; 4th European Conference on Infections in Leukemia (ECIL-4); joint venture of Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (IDWP-EBMT); Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (IDG-EORTC); International Immunocompromised Host Society (ICHS); European Leukemia Net (ELN) and European Study Group on Infections in Immunocompromised Hosts of the European Society for Clinical Microbiology and Infectious Diseases (ESGICH-ESCMID).

Clin Microbiol Infect. 2015 Mar;21(3):e25-7. doi: 10.1016/j.cmi.2014.10.014. Epub 2014 Dec 18. No abstract available.

16.

Rapid detection of enterovirus in cerebrospinal fluid by a fully-automated PCR assay is associated with improved management of aseptic meningitis in adult patients.

Giulieri SG, Chapuis-Taillard C, Manuel O, Hugli O, Pinget C, Wasserfallen JB, Sahli R, Jaton K, Marchetti O, Meylan P.

J Clin Virol. 2015 Jan;62:58-62. doi: 10.1016/j.jcv.2014.11.001. Epub 2014 Nov 10.

PMID:
25542472
17.

High-throughput hydrophilic interaction chromatography coupled to tandem mass spectrometry for the optimized quantification of the anti-Gram-negatives antibiotic colistin A/B and its pro-drug colistimethate.

Mercier T, Tissot F, Gardiol C, Corti N, Wehrli S, Guidi M, Csajka C, Buclin T, Couet W, Marchetti O, Decosterd LA.

J Chromatogr A. 2014 Nov 21;1369:52-63. doi: 10.1016/j.chroma.2014.09.063. Epub 2014 Oct 2.

PMID:
25441071
18.
19.

Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia.

Kumar V, Cheng SC, Johnson MD, Smeekens SP, Wojtowicz A, Giamarellos-Bourboulis E, Karjalainen J, Franke L, Withoff S, Plantinga TS, van de Veerdonk FL, van der Meer JWM, Joosten LAB, Bochud PY, Marchetti O, Perfect JR, Xavier R, Kullberg BJ, Wijmenga C, Netea MG.

Nat Commun. 2014 Sep 8;5:4675. doi: 10.1038/ncomms5675.

20.

Effective treatment of invasive Aspergillus fumigatus infection using combinations of topical and systemic antifungals in a severely burned patient.

Fournier A, Pantet O, Guerid S, Eggimann P, Pagani JL, Revelly JP, Hauser PM, Marchetti O, Fontanella S, Letovanec I, Ravat F, Berger MM, Pannatier A, Voirol P, Que YA.

J Burn Care Res. 2015 Mar-Apr;36(2):e85-9. doi: 10.1097/BCR.0000000000000143.

PMID:
25127025
21.

Polymorphisms in tumor necrosis factor-α increase susceptibility to intra-abdominal Candida infection in high-risk surgical ICU patients*.

Wójtowicz A, Tissot F, Lamoth F, Orasch C, Eggimann P, Siegemund M, Zimmerli S, Flueckiger UM, Bille J, Calandra T, Marchetti O, Bochud PY; Fungal Infection Network of Switzerland (FUNGINOS).

Crit Care Med. 2014 Apr;42(4):e304-8. doi: 10.1097/CCM.0000000000000208.

PMID:
24557424
22.

Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).

Averbuch D, Cordonnier C, Livermore DM, Mikulska M, Orasch C, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN.

Haematologica. 2013 Dec;98(12):1836-47. doi: 10.3324/haematol.2013.091330.

23.

European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.

Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, Gyssens IC, Kern WV, Klyasova G, Marchetti O, Engelhard D, Akova M; ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN.

Haematologica. 2013 Dec;98(12):1826-35. doi: 10.3324/haematol.2013.091025. Erratum in: Haematologica. 2014 Feb;99(2):400.

24.

Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.

Orasch C, Marchetti O, Garbino J, Schrenzel J, Zimmerli S, Mühlethaler K, Pfyffer G, Ruef C, Fehr J, Zbinden R, Calandra T, Bille J; FUNGINOS.

Clin Microbiol Infect. 2014 Jul;20(7):698-705. doi: 10.1111/1469-0691.12440. Epub 2013 Dec 12.

25.

β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis.

Tissot F, Lamoth F, Hauser PM, Orasch C, Flückiger U, Siegemund M, Zimmerli S, Calandra T, Bille J, Eggimann P, Marchetti O; Fungal Infection Network of Switzerland (FUNGINOS).

Am J Respir Crit Care Med. 2013 Nov 1;188(9):1100-9. doi: 10.1164/rccm.201211-2069OC.

PMID:
23782027
26.

Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.

Kern WV, Marchetti O, Drgona L, Akan H, Aoun M, Akova M, de Bock R, Paesmans M, Viscoli C, Calandra T.

J Clin Oncol. 2013 Mar 20;31(9):1149-56. doi: 10.1200/JCO.2012.45.8109. Epub 2013 Jan 28.

PMID:
23358983
27.

[Antimicrobial agents and renal elimination: towards individual dosage adjustment?].

Willi-Robatel C, Senn L, Livio F, Zanetti G, Marchetti O, Buclin T.

Rev Med Suisse. 2012 Apr 25;8(338):894-900. Review. French.

PMID:
22611626
28.

Challenging recommended oral and intravenous voriconazole doses for improved efficacy and safety: population pharmacokinetics-based analysis of adult patients with invasive fungal infections.

Pascual A, Csajka C, Buclin T, Bolay S, Bille J, Calandra T, Marchetti O.

Clin Infect Dis. 2012 Aug;55(3):381-90. doi: 10.1093/cid/cis437. Epub 2012 May 18.

PMID:
22610925
29.

β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).

Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O; Third European Conference on Infections in Leukemia (ECIL-3).

Clin Infect Dis. 2012 Mar 1;54(5):633-43. doi: 10.1093/cid/cir897. Epub 2011 Dec 23. Review.

PMID:
22198786
30.

Response to: lack of intra-laboratory reproducibility in using Platelia Aspergillus enzyme immunoassay test for detection of Aspergillus galactomannan antigen.

Bizzini A, Marchetti O, Meylan P.

Transpl Infect Dis. 2012 Apr;14(2):218-9. doi: 10.1111/j.1399-3062.2011.00707.x. Epub 2011 Dec 20. No abstract available. Erratum in: Transpl Infect Dis. 2012 Jun;14(3):332.

PMID:
22188592
31.

Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis?

Eggimann P, Marchetti O.

Crit Care. 2011;15(6):1017. doi: 10.1186/cc10544. Epub 2011 Dec 5.

32.

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients.

Marchetti O, Lamoth F, Mikulska M, Viscoli C, Verweij P, Bretagne S; European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups.

Bone Marrow Transplant. 2012 Jun;47(6):846-54. doi: 10.1038/bmt.2011.178. Epub 2011 Sep 19. Review.

PMID:
21927034
33.

Diagnosis of invasive candidiasis in the ICU.

Eggimann P, Bille J, Marchetti O.

Ann Intensive Care. 2011 Sep 1;1:37. doi: 10.1186/2110-5820-1-37.

34.

Voriconazole-induced periostitis.

Rossier C, Dunet V, Tissot F, Aubry-Rozier B, Marchetti O, Boubaker A.

Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):375-6. doi: 10.1007/s00259-011-1922-x. Epub 2011 Sep 6. No abstract available. Erratum in: Eur J Nucl Med Mol Imaging. 2012 Feb;39(2):377. Marchetti, Olivier [corrected to Marchetti, Oscar]..

PMID:
21894545
35.

Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?

Robinson JO, Lamoth F, Bally F, Knaup M, Calandra T, Marchetti O.

PLoS One. 2011 Apr 25;6(4):e18886. doi: 10.1371/journal.pone.0018886.

36.

Treatment and timing in invasive mould disease.

Maertens J, Groll AH, Cordonnier C, de la Cámara R, Roilides E, Marchetti O.

J Antimicrob Chemother. 2011 Jan;66 Suppl 1:i37-43. doi: 10.1093/jac/dkq440. Review.

PMID:
21177402
37.

Ultra-performance liquid chromatography mass spectrometry and sensitive bioassay methods for quantification of posaconazole plasma concentrations after oral dosing.

Rochat B, Pascual A, Pesse B, Lamoth F, Sanglard D, Decosterd LA, Bille J, Marchetti O.

Antimicrob Agents Chemother. 2010 Dec;54(12):5074-81. doi: 10.1128/AAC.00022-10. Epub 2010 Oct 4.

38.

Multiplex ultra-performance liquid chromatography-tandem mass spectrometry method for simultaneous quantification in human plasma of fluconazole, itraconazole, hydroxyitraconazole, posaconazole, voriconazole, voriconazole-N-oxide, anidulafungin, and caspofungin.

Decosterd LA, Rochat B, Pesse B, Mercier T, Tissot F, Widmer N, Bille J, Calandra T, Zanolari B, Marchetti O.

Antimicrob Agents Chemother. 2010 Dec;54(12):5303-15. doi: 10.1128/AAC.00404-10. Epub 2010 Sep 20.

39.

Invasive candidiasis in critically ill patients: does progressing knowledge improve clinical management and outcome?

Marchetti O, Eggimann P, Calandra T.

Curr Opin Crit Care. 2010 Oct;16(5):442-4. doi: 10.1097/MCC.0b013e32833e2629. No abstract available.

PMID:
20827072
40.

Multiplex blood PCR in combination with blood cultures for improvement of microbiological documentation of infection in febrile neutropenia.

Lamoth F, Jaton K, Prod'hom G, Senn L, Bille J, Calandra T, Marchetti O.

J Clin Microbiol. 2010 Oct;48(10):3510-6. doi: 10.1128/JCM.00147-10. Epub 2010 Aug 18.

41.

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update.

Maertens J, Marchetti O, Herbrecht R, Cornely OA, Flückiger U, Frêre P, Gachot B, Heinz WJ, Lass-Flörl C, Ribaud P, Thiebaut A, Cordonnier C; Third European Conference on Infections in Leukemia.

Bone Marrow Transplant. 2011 May;46(5):709-18. doi: 10.1038/bmt.2010.175. Epub 2010 Jul 26.

PMID:
20661235
42.

High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.

Lamoth F, Buclin T, Pascual A, Vora S, Bolay S, Decosterd LA, Calandra T, Marchetti O.

Antimicrob Agents Chemother. 2010 Oct;54(10):4360-7. doi: 10.1128/AAC.01595-08. Epub 2010 Jul 12.

43.

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study.

Herbrecht R, Maertens J, Baila L, Aoun M, Heinz W, Martino R, Schwartz S, Ullmann AJ, Meert L, Paesmans M, Marchetti O, Akan H, Ameye L, Shivaprakash M, Viscoli C.

Bone Marrow Transplant. 2010 Jul;45(7):1227-33. doi: 10.1038/bmt.2009.334. Epub 2010 Jan 11.

PMID:
20062093
44.

An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.

Viscoli C, Herbrecht R, Akan H, Baila L, Sonet A, Gallamini A, Giagounidis A, Marchetti O, Martino R, Meert L, Paesmans M, Ameye L, Shivaprakash M, Ullmann AJ, Maertens J; Infectious Disease Group of the EORTC.

J Antimicrob Chemother. 2009 Dec;64(6):1274-81. doi: 10.1093/jac/dkp355. Epub 2009 Oct 19.

PMID:
19841031
45.
46.

High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction.

Lamoth F, Erard V, Asner S, Buclin T, Calandra T, Marchetti O.

Int J Antimicrob Agents. 2009 Oct;34(4):386-8. doi: 10.1016/j.ijantimicag.2009.06.001. Epub 2009 Jul 10. No abstract available.

PMID:
19596561
47.

Imipenem underdosing as a cause of persistent neutropenic fever?

Lamoth F, Buclin T, Pascual A, Calandra T, Marchetti O.

J Antimicrob Chemother. 2009 Sep;64(3):665-7. doi: 10.1093/jac/dkp233. Epub 2009 Jul 7. No abstract available.

PMID:
19584103
48.

On track to limit antifungal overuse!

Eggimann P, Lamoth F, Marchetti O.

Intensive Care Med. 2009 Apr;35(4):582-4. doi: 10.1007/s00134-009-1432-5. Epub 2009 Feb 11. No abstract available. Erratum in: Intensive Care Med. 2009 Apr;35(4):772.

PMID:
19205661
49.

Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients.

Senn L, Eggimann P, Ksontini R, Pascual A, Demartines N, Bille J, Calandra T, Marchetti O.

Intensive Care Med. 2009 May;35(5):903-8. doi: 10.1007/s00134-009-1405-8. Epub 2009 Jan 27.

PMID:
19172247
50.

Reassessment of recommended imipenem doses in febrile neutropenic patients with hematological malignancies.

Lamoth F, Buclin T, Csajka C, Pascual A, Calandra T, Marchetti O.

Antimicrob Agents Chemother. 2009 Feb;53(2):785-7. doi: 10.1128/AAC.00891-08. Epub 2008 Dec 1.

Supplemental Content

Loading ...
Support Center